TDP43 Promotes Stemness of Breast Cancer Stem Cells through CD44 Variant Splicing Isoforms

Investigators found that loss of TAR DNA-binding protein-43 (TDP43) inhibited breast cancer stem cell stemness by reducing the abundance of cluster of differentiation 44 (CD44) variant alternative splicing isoforms.